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Prostaglandin E2Hydrogen sulﬁde (H2S) is a gaseous neuromodulator endogenously produced in the brain by the enzyme
cystathionine β-synthase (CBS). We tested the hypothesis that H2S acts within the anteroventral preoptic re-
gion of the hypothalamus (AVPO) modulating the production of prostaglandin (PG) E2 (the proximal medi-
ator of fever) and cyclic AMP (cAMP). To this end, we recorded deep body temperature (Tb) of rats before and
after pharmacological modulation of the CBS–H2S system combined or not with lipopolysaccharide (LPS) ex-
posure, and measured the levels of H2S, cAMP, and PGE2 in the AVPO during systemic inﬂammation. Intra-
cerebroventricular (icv) microinjection of aminooxyacetate (AOA, a CBS inhibitor; 100 pmol) did not affect
basal PGE2 production and Tb, but enhanced LPS-induced PGE2 production and fever, indicating that endog-
enous H2S plays an antipyretic role. In agreement, icv microinjection of a H2S donor (Na2S; 260 nmol) re-
duced the LPS-induced PGE2 production and fever. Interestingly, we observed that the AVPO levels of H2S
were decreased following the immunoinﬂammatory challenge. Furthermore, fever was associated with de-
creased levels of AVPO cAMP and increased levels of AVPO PGE2. The LPS-induced decreased levels of
cAMP were reduced to a lesser extent by the H2S donor. The LPS-induced PGE2 production was potentiated
by AOA (the CBS inhibitor) and inhibited by the H2S donor. Our data are consistent with the notion that
the gaseous messenger H2S synthesis is downregulated during endotoxemia favoring PGE2 synthesis and
lowering cAMP levels in the preoptic hypothalamus.
© 2012 Elsevier Inc. Ope n access under the Elsevier OA license. Introduction
Prostaglandin E2 (PGE2) is known to play a key role in mediating
inﬂammation. In systemic inﬂammation, the production of PGE2 has
been reported to occur in peripheral tissues and also in the brain
(Steiner et al., 2006). As a result, a number of reactions (namely
acute-phase reaction) take place during systemic inﬂammation, in-
cluding fever, a brain-mediated response typically generated and con-
trolled in the anteroventral preoptic region of the hypothalamus
(AVPO). Fever, a regulated increase in deep body temperature (Tb)
that favors the activity of the immune system, is not only the hallmark
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 OA license. other microbial products that can trigger fever, lipopolysaccharide
(LPS) of the outer membrane of Gram-negative bacteria has been the
most used experimental tool to study fever.
Modulators are known to increase (propyretic) or decrease (anti-
pyretic) the febrile response to LPS. Among them, the gaseous neu-
romodulators nitric oxide (NO) (Steiner et al., 2002a, 2002b) and
carbon monoxide (CO) (Steiner and Branco, 2001) acting in the
brain have been reported to modulate fever.
Recently, a third gaseous transmitter that regulates neuronal activ-
ity has been reported (Kimura et al., 2005). Hydrogen sulﬁde (H2S)
production is mainly catalyzed in the brain by the enzyme cyst-
athionine β-synthase (CBS) (Abe and Kimura, 1996; Enokido et al.,
2005; Lee et al., 2009), whereas in peripheral tissues by cystathionine
γ-lyase (CSE) (Yang et al., 2008).
H2S acts on biological systems via a number of interconnected
mechanisms (Wagner et al., 2009). Besides regulating neuronal ac-
tivity (Kimura et al., 2005), H2S has been documented to inhibit
NFkappaB activity (Lee et al., 2009), affecting PGE2 production (Li
et al., 2009), and stimulate cAMP synthesis (Kimura, 2000; Shao
et al., 2011) particularly in the anterior hypothalamus (Kwiatkoski
et al., 2012). Considering that PGE2 is the proximal mediator of fever,
and that preoptic cAMP levels profoundly inﬂuence the activity of
warm-sensitive neurons (Boulant, 1998), modulating fever (Steiner
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H2S in the AVPO may exert a considerable impact on the febrile re-
sponse to LPS.
Thus, in the present study we addressed the following key ques-
tions: Is H2S endogenously produced in the AVPO? Does this gas play
a thermoregulatory role during LPS fever? And if so, does the H2S ef-
fect depend on AVPO cAMP and/or PGE2 production?
Materials and methods
Animals
Adult male Wistar rats, obtained from institutional vivarium
sources, were group-housed (4 animals per cage) and acclimated for
1 week before experimental use. The rats had free access to water
and food and were housed in a temperature-controlled chamber at
24–25 °C (model: ALE 9902001; Alesco Ltda., Monte Mor, SP, Brazil),
with a 12:12-h light:dark cycle (lights on at 6:00 AM). All experi-
ments were performed on rats weighing 260–300 g at the time of
the experiments, hydrated and fed ad libitum. Animal care was carried
out in compliance with the guidelines set by the Brazilian College of
Animal Experimentation (COBEA), an afﬁliate of the International
Council for Laboratory Animal Science (ICLAS), which included mini-
mizing the number of animals used and their suffering, and had the
approval of the Animal Care and Use Committee of the University of
São Paulo.
Surgeries
Surgical procedures were performed under ketamine-xylazine an-
esthesia (100 and 10 mg/kg, respectively; 1 ml/kg, intraperitoneal).
Anesthetized animals were ﬁxed (prostrate) on a stereotaxic frame
to be implanted with a stainless steel guide cannula (15-mm long,
22-gauge outer diameter) in the third ventricle (3 V) for intracerebro-
ventricular (icv) microinjection, according to the following stereo-
taxic coordinates (Paxinos and Watson, 2007): anteroposterior:
−0.4 mm, lateral: 0.0 mm, and dorsoventral:−7.5 mm from bregma.
The guide cannula was ﬁxed to the skull with stainless steel screws and
acrylic cement. A tightly ﬁtting styletwas inserted into the guide cannu-
la to maintain patency and prevent infection. Afterwards, a median
laparotomy was performed so as to insert a temperature datalogger
capsule (SubCue, Calgary, AB, Canada) into the peritoneal cavity to re-
cord deep body temperature (Tb). All animalswere kept under deep an-
esthesia throughout the surgical procedures. During the last half of the
surgical procedures period, around 10% of the rats responded to algesic
stimulus (evoked by a pinch applied to the tail) and then received a
supplementary dose of anesthetic. Antibiotic solution (160,000 U/kg
benzylpenicilin, 33.3 mg/kg streptomycin, and 33.3 mg/kg dihydro-
streptomycin; 1 ml/kg, intramuscular) and analgesic medication
(Flunexine; 2.5 mg/kg, 1 ml/kg, subcutaneous) were provided immedi-
ately after the surgical procedures. Prior to the experimental procedures,
the animals were allowed to recover from the surgical interventions for
5 days.
Drugs
Aminooxyacetate (AOA; inhibitor of the enzyme CBS), sodium sul-
ﬁde (Na2S; a donor of H2S), and bacterial lipopolysaccharide (LPS, se-
rotype 0111: b4) were purchased from Sigma (St. Louis, MO, USA).
These drugs were dissolved in pyrogen-free saline.
Microinjection
To perform icv microinjection, we used a microinjection device
(model 310, Stoelting, Wood Dale, IL, USA) and a 10-μl syringe
(Hamilton, Reno, NV, USA) connected to a microinjection needle(30-gauge outer diameter) with a polyethylene tube (PE 10). Micro-
injection was performed at a ﬂow rate of 50 nl/min. The microinjec-
tion needle, 0.1 mm longer than the guide cannula, was inserted
into the guide cannula solely at the moment of the microinjection.
Tb recordings
The animals used to perform the in vivo experiments (1, 2, 3 and
4) had their Tb recorded at 5-min intervals for 6 h with the tempera-
ture datalogger capsule (SubCue, Calgary, AB, Canada) inserted into
the peritoneal cavity.
AVPO sampling
The rats used to assess ex vivo the AVPO levels of H2S, NOx, cGMP,
cAMP and PGE2 (experiments 5 and 6) were decapitated 2 h after
treatments (ip injection and icv microinjection), and their brains
were quickly excised and promptly frozen by submersion in dry ice-
cold isopentane, and stored at −70 °C. Each brain was serially sec-
tioned in a cryostat from the caudal end so as to reach the AVPO. We
then sectioned a 500-μm-thick slice of the hypothalamus, and bilateral
samples of the AVPO were excised with a punch needle (2-mm outer
diameter).
Assessment of H2S concentration in the AVPO
H2S levels were measured as described elsewhere (Francescato et
al., 2011; Kwiatkoski et al., 2012; Singh et al., 2009; Stipanuk and
Beck, 1982). Brieﬂy, AVPO bilateral samples were homogenized in po-
tassium phosphate buffer (100 mM; pH 7.4) using a microprocessor
(VirTis, Gardiner, NY, USA). Each sample (50% w/v; 100 μl) contained
L-cysteine (10 mM; 20 μl), pyridoxal 5′-phosphate (2 mM; 20 μl)
and PBS (30 μl). The reaction was performed in paraﬁlmed eppendorf
tubes and initiated by transferring the tubes from ice to bath at 37 °C.
After incubation for 2 h, zinc acetate (1% w/v; 100 μl) was added to
trap evolved H2S followed by tricloroacetic acid (10% w/v; 100 μl) to
precipitate proteins and thus stop the reaction. After centrifugation,
N,N-dimethyl-p-phenylenediamine sulphate (20 mM; 50 μl) in HCl
7.2 M followed by FeCl3 (30 mM; 50 μl) in HCl 1.2 M was then
added to 50 μl of the supernatant, and optical density was measured
at 670 nm. The calibration curve of absorbance was obtained using
Na2S solutions (0.1–100 μg/ml). To assess the protein content of the
samples, the pellets were diluted in 4 ml of sodium hydroxide
(0.1 N). The solution was then assayed by using a protein dye reagent
(Bio-Rad Laboratories; Hercules, CA, USA; code number: 500-0006).
Assessment of NOx concentration in the AVPO
NOx levels were assessed as previously described (Kwiatkoski et al.,
2012; Soriano et al., 2010, 2012). AVPO bilateral samples were homog-
enized on ice in 100 μl of acetic acid solution (0.1 N) using the micro-
processor (VirTis, Gardiner, NY, USA). Brieﬂy, the homogenates were
centrifuged at 10,000 g for 10 min at 2 °C, and the resultant pellets
were later processed to assess the protein content, as brieﬂy described
above. Absolute ethanol (60 μl) was then added to 30 μl of the superna-
tant and, after a 30-min period at 0 °C, the samples were centrifuged at
10,000 g for 5 min. The supernatant (5 μl) was injected into a NO ana-
lyzer (model 280, Sievers Instruments, Boulder, CO, USA) to assess
NOx concentration by NO–ozone chemiluminescence technique.
Assessment of cGMP concentration in the AVPO
cGMP levels were assessed as previously described (Kwiatkoski
et al., 2012; Soriano et al., 2010). AVPO bilateral samples were ho-
mogenized on ice using the microprocessor (VirTis, Gardiner, NY,
USA) in 100 μl of a 6% (w/v) TCA solution. Brieﬂy, the homogenates
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tant pellets were processed to assess the protein content, as brieﬂy
described above. The TCA was extracted with diethyl ether, and the
samples were lyophilized. The samples were reconstituted in an
assay buffer (2 ml) available in the Amersham Pharmacia Biotech
kit (Piscataway, NJ, USA; code number RPN226), and cGMP concen-
tration was assessed by enzyme immunoassay (EIA) according to
the manufacturer's instructions.
Assessment of cAMP concentration in the AVPO
cAMP levels were assessed as previously described (Kwiatkoski et
al., 2012). AVPO bilateral samples were homogenized on ice in 150 μl
of a 6% (w/v) trichloroacetic acid (TCA) solution using the micropro-
cessor (VirTis, Gardiner, NY, USA). Brieﬂy, the resulting homogenates
were then centrifuged at 10,000 g for 10 min at 2 °C and the pellets
processed for protein determination, as brieﬂy described above. The
TCA was extracted with water-saturated diethyl ether, and the sam-
ples were lyophilized. The samples were then reconstituted in 8 ml
of the assay buffer provided in the kit (Amersham Pharmacia Biotech,
Piscataway, NJ, USA; code number: RPN225), and cAMP concentra-
tion was determined by enzyme immunoassay according to
manufacturer's instructions.
Assessment of PGE2 concentration in the AVPO
PGE2 levels were assessed as described in our previous reports
(Soriano and Branco, 2010; Soriano et al., 2011). AVPO bilateral sam-
ples were homogenized (VirTis, Gardiner, NY, USA) on ice inmethanol
(150 μl) containing indomethacin (1 M). Brieﬂy, the homogenates
were centrifuged at 10,000 g for 10 min at 2 °C. The resulting super-
natants and pellets were used for PGE2 and protein determination,
respectively. The samples were reconstituted in the assay buffer pro-
vided in the kit (Cayman, 500141 PGE2 EIA Kit), and PGE2 levels
were measured using enzyme immunoassay according to the
manufacturer's instructions.
Experimental protocols
In all experimental protocols, 24 h before the experimental proce-
dures, the animals were placed in an experiment roomwith tempera-
ture set at 24 °C; this ambient temperature was maintained constant
throughout the experiments. Doses of AOA and Na2S tested in pilot ex-
periments were based on the literature (Kwiatkoski et al., 2012), and
those that produced consistent, repeatable responses were adopted
in the present study.
Experiments 1–4 aimed at investigating the effects of the pharma-
cological tools on Tb (in euthermic and febrile rats). In another group
of animals, rats were decapitated at the peak of the effervescence
phase of the LPS-induced fever, i.e., 2 h after LPS injection, to measure
the concentration of H2S, NOx, cGMP, cAMP and PGE2 in the AVPO
(Experiments 5–6).
Experiment 1: Effect of icv microinjection of AOA on Tb of euthermic rats
To investigate the putative central effect of CBS inhibition on Tb
during euthermia, unanesthetized, freely moving rats received ip in-
jection of saline (1 ml/kg) followed by microinjection of AOA (100
or 300 pmol/2 μl) or saline (2 μl) into the 3 V. Tb was recorded for
7 h, starting 1 h before treatments.
Experiment 2: Effect of icv microinjection of Na2S on Tb of euthermic rats
Wealso investigated the putative effect of increased central bioavail-
ability of H2S on the control of Tb of euthermic rats. Unanesthetized,
freely moving rats received ip injection of saline (1 ml/kg) followed bymicroinjection of Na2S (260 nmol/2 μl) or saline (2 μl) into the 3 V. Tb
was recorded for 7 h, starting 1 h before treatments.
Experiment 3: Effect of icv microinjection of AOA on LPS-induced fever
The putative central effect of CBS inhibition during LPS-induced
fever was evaluated in unanesthetized, freely moving rats that re-
ceived ip injection of LPS (100 μg/kg,1 ml/kg) followed by microin-
jection of AOA (100 pmol/2 μl) or saline (2 μl) into the 3 V. Tb was
recorded for 7 h, starting 1 h before treatments.
Experiment 4: Effect of icv microinjection of Na2S on LPS-induced fever
To investigate the putative effect of increased central bioavailabil-
ity of H2S, unanesthetized, freely moving rats were microinjected into
the 3 Vwith a H2S donor (Na2S; 260 nmol/2 μl) or saline (2 μl) imme-
diately after ip injection of LPS (100 μg/kg,1 ml/kg). Tb was recorded
for 7 h, starting 1 h before treatments.
Experiment 5: Assessment of the AVPO levels of H2S during euthermia
and LPS-induced fever
Following the in vivo approaches, we assessed the levels of H2S
production in the AVPO of euthermic and febrile rats. Unanesthetized,
freely moving rats received ip injection of LPS (100 μg/kg,1 ml/kg) or
saline (1 ml/kg), and 2 h after the animals were decapitated and the
brains processed as described above for the H2S measurement.
Experiment 6: Effect of icv microinjection of AOA or Na2S on NOx, cGMP,
cAMP and PGE2 levels in the AVPO during euthermia and LPS-induced
fever
We also measured ex vivo in the AVPO of euthermic and febrile
rats the putative central effects of (i) inhibition of the CBS or (ii) in-
creased bioavailability of H2S on the levels of NOx, cGMP, cAMP and
PGE2. The animals received ip injection of LPS (100 μg/kg,1 ml/kg)
or saline (1 ml/kg) followed by microinjection into the 3 V of AOA
(100 pmol/2 μl), Na2S (260 nmol/2 μl), or vehicle (saline, 2 μl).
After 2 h, the animals were decapitated and the brains processed as
described above for each speciﬁc measurement.
Statistical analysis
The values are expressed as mean±SE. Unpaired t test or one-way
ANOVA followed by Tukey post hoc test was used to assess statistical
differences among groups in the in vivo experiments (Tb recordings)
after area under curve was calculated (thermal/fever index) for each
animal's Tb recording, adopting as baseline 36 °C; since thermal/
fever index represent area under curve, this index is expressed in
°C×min. One-way ANOVA followed by Tukey post hoc test was used
to assess statistical differences in the other experimental protocols
(ex vivo measurements). Values of Pb0.05 were considered statisti-
cally signiﬁcant.
Results
Effect of AOA and Na2S on Tb of euthermic rats
Before investigating the putative effect of AOA and Na2S on LPS
fever, we performed a set of experiments to evaluate whether the
CBS inhibitor and the H2S donor at a given dose would affect Tb
control during euthermia. Intracerebroventricular microinjection of
the high dose of AOA evoked a marked, signiﬁcant increase in Tb
not only when compared to the saline-treated group (Pb0.001; 95%
CI: −413.3 to −127.1; saline: 230.3±28.32 °C×min, n=5, vs. AOA
(high dose): 500.5±27.13 °C×min, n=4) but also when compared
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−368.1 to −92.59). In contrast, the low dose of AOA did not cause
any considerable effect on Tb when compared to the saline-treated
group (P>0.05; 95% CI: −169.1 to 89.34; AOA (low dose): 270.2±
41.59 °C×min, n=6) (Figs. 1A and B). As to the Na2S, icv microinjec-
tion of this H2S donor did not signiﬁcantly affect Tb when compared
to the saline-treated group (P=0.9701; 95% CI:−102.5 to 106.1; saline
group: 230.3±28.32 °C×min, n=5, vs. Na2S: 228.5±34.72 °C×min,
n=6) (Figs. 1C and D). The doses of AOA and Na2S adopted in the pres-
ent study were based on pilot experiments and a previous report
(Kwiatkoski et al., 2012).
Effect of AOA and Na2S on LPS-induced fever
Since the low dose of AOA and Na2S did not affect Tb control during
euthermia, our next stepwas to investigatewhether at these doses the
drugs modulate the febrile response to LPS. Intraperitoneal injection
of LPS evoked the typical regulated increase in Tb (the well known
LPS-induced fever) (392.6±19.86 °C×min, n=7). When the injec-
tion of LPS was combined with icv microinjection of AOA, LPS fever
was signiﬁcantly increased (Pb0.05; 95% CI: −240.9 to −0.5645;Fig. 1. AOA at 100 pmol does not induce increase and the H2S donor (Na2S) at 260 nmol do
microinjection of AOA at 100 or 300 pmol in 2 μl or vehicle (saline, 2 μl) on deep body temp
by the horizontal bar) clariﬁes the results observed in the time courses. C: Time courses sho
on Tb of euthermic rats. D: Thermal index (area under curve indicated in panel C by the hor
ment of the microinjection. Values are means±SE. Number of animals in each group is show
followed by Tukey post hoc test.saline: 392.6±19.86 °C×min, n=7, vs. AOA: 513.3±48.96 °C×min,
n=6). In the opposite direction, LPS injection combined with icv mi-
croinjection of Na2S (251.2±28.05 °C×min, n=6) attenuated fever
(Pb0.05; 95% CI: 21.19 to 261.5, compared to saline) (Figs. 2A and B).AVPO levels of H2S
To further explore the involvement of H2S in LPS fever, besides in-
vestigating the effects on fever of central pharmacological modula-
tion of the CBS–H2S system in vivo, we assessed the levels of H2S
endogenously produced in the region of the brain known to be crucial
for the generation and control of fever, the AVPO. Basal levels of AVPO
H2S in naïve rats were 0.5870±0.04893 μg/mg protein/h, n=10. The
animals injected with saline or LPS were decapitated 2 h after the in-
jection for subsequent AVPO sampling. Injection of saline (0.5514±
0.06344 μg/mg protein/h, n=9) did not signiﬁcantly alter the AVPO
H2S levels (P>0.05; 95% CI: −0.1590 to 0.2301). Differently, LPS in-
duced a pronounced reduction of H2S production in the AVPO
(Pb0.01; 95% CI: 0.06788 to 0.4732 vs. naïve rats; Pb0.05; 95% CI:
0.001355 to 0.4686 vs. saline) (Fig. 3).es not evoke decrease in Tb of euthermic rats. A: Time courses showing the effect of icv
erature (Tb) of euthermic rats. B: Thermal index (area under curve indicated in panel A
wing the effect of icv microinjection of Na2S (260 nmol in 2 μl) or vehicle (saline, 2 μl)
izontal bar) clariﬁes the results observed in the time courses. Arrow indicates the mo-
n in parenthesis. ⁎Pb0.05 vs. AOA at 100 pmol, #Pb0.05 vs. saline, by one-way ANOVA
Fig. 2. AOA at 100 pmol exacerbates whereas Na2S at 260 nmol attenuates LPS fever. A: Time courses showing the effect of icv microinjection of AOA (100 pmol in 2 μl), Na2S
(260 nmol in 2 μl) or vehicle (saline, 2 μl) on fever induced by injection of LPS (100 μg/kg, ip). B: Fever index (area under curve indicated in panel A by the horizontal bar) clariﬁes
the results observed in the time courses. Arrow indicates the moment of the icv microinjection and ip injection. Values are means±SE. Number of animals in each group is shown in
parenthesis. ⁎Pb0.05 vs. Na2S, #Pb0.05 vs. saline, by one-way ANOVA followed by Tukey post hoc test.
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Since it is known that the levels of both NO and cGMP are reduced
in the AVPO during fever, we investigated whether H2S may affect the
AVPO levels of NO and/or cGMP. The animals in this experimental pro-
tocol received an icv bolus microinjection of AOA, Na2S or saline im-
mediately followed by an ip bolus injection of LPS or saline before
being decapitated 2 h after these treatments for subsequent AVPO
sampling. In the groups of rats treated ip with saline, icv treatment
with AOA or Na2S did not signiﬁcantly alter (P>0.05) the AVPO NOx
levels when compared to the group treated with saline given icv.
Similarly, in LPS-treated rats, AOA (4.291±1.055 pmol/μg protein,
n=8) or Na2S (5.080±0.8745 pmol/μg protein, n=8) did not signif-
icantly affect (P>0.05) the AVPO NOx levels when compared to the
group treated with saline given icv (3.900±0.5322 pmol/μg protein,
n=7). Comparing the groups treated ip with saline to the groups
treated ip with LPS, we observed that the ip injection of LPS, in all
three groups of rats, induced a reduction of the AVPO NOx levels;
such reduction was statistically signiﬁcant when the group treated
with LPS ip combined with saline icv was compared to the groupFig. 3. H2S levels are reduced in the AVPO during LPS fever. Basal levels and effect of
injection of LPS (100 μg/kg, ip) or saline (1 ml/kg, ip) on the AVPO levels of H2S. Values
are means±SE. Number of animals in each group is shown in parenthesis. ⁎Pb0.05 vs.
saline, #Pb0.05 vs. naïve, by one-way ANOVA followed by Tukey post hoc test.treated with saline ip combined with saline given icv (Pb0.05; 95%
CI: 0.05846 to 7.562; saline ip+saline icv: 7.710±0.6034 pmol/μg
protein, n=8, vs. LPS ip+saline icv: 3.900±0.5322 pmol/μg protein,
n=7) (Fig. 4A). As to the levels of cGMP in the AVPO, in the groups of
rats treated ip with saline, icv treatment with AOA or Na2S did not sig-
niﬁcantly alter (P>0.05) the AVPO cGMP levelswhen compared to the
group treated icv with saline (1.629±0.1272 fmol/μg protein, n=8).
Similarly, in LPS-treated rats, AOA (0.8525±0.1129 fmol/μg protein,
n=8) or Na2S (0.5013±0.1172 fmol/μg protein, n=8) did not sig-
niﬁcantly affect (P>0.05) the AVPO cGMP levels when compared to
the group treated icv with saline (0.5171±0.1020 fmol/μg protein,
n=7). When comparing the groups treated ip with saline to the
groups treated ip with LPS, we observed that LPS evoked a signiﬁcant
reduction of AVPO cGMP (Pb0.01; 95% CI: 0.3095 to 1.914, comparing
saline ip+saline icv with LPS ip+saline icv) (Fig. 4B).AVPO levels of cAMP
Besides cGMP, it is also known that cAMP levels in the AVPO are re-
duced during fever. Therefore, we then explored the possibility that
H2S is able tomodulate adenylate cyclase activity in this hypothalamic
region following LPS exposure, i.e., during the febrile response to LPS.
The animals in this experimental protocol received an icv bolusmicro-
injection of AOA, Na2S or saline immediately followed by an ip bolus
injection of LPS or saline before being decapitated 2 h after these
treatments for subsequent AVPO sampling. Basal levels of cAMP
were 16.08±0.9281 fmol/μg protein, n=8. In the groups of rats treat-
ed ip with saline, icv treatment with AOA or Na2S did not signiﬁcantly
alter (P>0.05) the AVPO cAMP levels when compared to the group
treated icv with saline. LPS treatment signiﬁcantly reduced (Pb0.05)
the AVPO cAMP levels in all three groups investigatedwhen compared
to the saline-treated groups (Pb0.001; 95% CI: 4.926 to 13.14, compar-
ing saline ip+saline icv: 16.08±0.9281 fmol/μg protein, n=8, with
LPS ip+saline icv: 7.043±0.4325 fmol/μg protein, n=7). Despite
not statistically signiﬁcant, when compared with the group treated
with LPS (ip) combined with saline (icv), AOA tended to exacerbate
the reduction of the AVPO levels of cAMP (P>0.05; 95% CI: −3.213
to 4.999). Interestingly, in the group of rats treated with LPS (ip)
combined with the H2S donor (icv) (11.50±0.6053 fmol/μg protein,
n=8) the LPS-induced reduction of the AVPO cAMP levels was less
pronounced (Pb0.05; 95% CI: −8.563 to −0.3509, compared with
Fig. 4. Neither AOA nor Na2S affects the AVPO levels of NOx and cGMP. A: Effect of injection of LPS (100 μg/kg, ip) or saline (1 ml/kg, ip) combined with icv microinjection of AOA
(100 pmol in 2 μl), Na2S (260 nmol in 2 μl) or vehicle (saline, 2 μl) on AVPO nitrite/nitrate (NOx) levels. B: Effect of the same treatments (described in panel A) on AVPO cGMP
levels. Values are means±SE. Number of animals in each group is shown in parenthesis. #Pb0.05 vs. groups treated ip with saline, by one-way ANOVA followed by Tukey post
hoc test.
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with LPS ip+AOA icv: 6.150±0.5904 fmol/μg protein, n=8) (Fig. 5).AVPO levels of PGE2
Considering the fact that the AVPO levels of the proximal media-
tor of fever, PGE2, are known to be increased following LPS challenge,
we investigated whether H2S may modulate the production of this
prostanoid. The animals in this experimental protocol received an icv
bolus microinjection of AOA, Na2S or saline immediately followed by
an ip bolus injection of LPS or saline before being decapitated 2 h after
these treatments for subsequent AVPO sampling. As expected, treat-
ment with LPS evoked a signiﬁcant (Pb0.05) elevation in the AVPO
PGE2 levels when compared to the saline-treated groups. In the groups
injected ip with saline, neither AOA nor Na2S signiﬁcantly affected PGE2
production (P>0.05). As to the effects of these drugs during fever, i.e., in
the LPS-treated groups, AOA further increased (Pb0.05; 95% CI:−117.0
to −1.705; from 185.6±19.27 ng/mg protein, n=7, to 244.9±
15.78 ng/mg protein, n=8), whereas Na2S signiﬁcantly reduced
(Pb0.05; 95% CI: 6.922 to 122.2) the AVPO levels of PGE2 (from
185.6±19.27 ng/mg protein, n=7, to 121.0±20.76 ng/mg protein,
n=8) (Fig. 6).Fig. 5. Na2S stimulates AVPO cAMP production during fever. Effect of injection of LPS
(100 μg/kg, ip) or saline (1 ml/kg, ip) combined with icv microinjection of AOA
(100 pmol in 2 μl), Na2S (260 nmol in 2 μl) or vehicle (saline, 2 μl) on AVPO cAMP
levels. Values are means±SE. Number of animals in each group is shown in parenthe-
sis. ⁎Pb0.05 vs. AOA+LPS, @Pb0.05 vs. saline+LPS, #Pb0.05 vs. groups treated ip with
saline, by one-way ANOVA followed by Tukey post hoc test.Discussion
The ﬁndings of the present study are consistent with the notion
that LPS exposure reduces the AVPO levels of H2S besides increasing
the activity of AVPO COX-2/microsomal PGE synthase-1 (mPGES-1),
which is known to ultimately result in the febrile response to LPS.
Since we demonstrated that pharmacological inhibition of CBS in
rats challenged with LPS (i) further increased the AVPO levels of the
proximal mediator of fever, PGE2, (ii) induced an exaggerated fever,
and (ii) tended to exacerbate the reduction of AVPO cAMP, we con-
jecture that the LPS-induced AVPO reduced levels of H2S diminish
the suppression by H2S of the AVPO levels of PGE2 thus favoring the
occurrence of the typical regulated increase in Tb (fever). Together
with the results of the other experimental protocols of the present
study in which the H2S donor was used, these exciting ﬁndings with
the CBS inhibitor provide solid evidence not only in vivo but also ex
vivo that allow us to suggest that H2S is a powerful endogenous anti-
pyretic molecule in the preoptic hypothalamus.
In the central nervous system, H2S is produced by the enzyme CBS,
which has been demonstrated to be expressed mainly in astrocytes
(Chen et al., 2004; Enokido et al., 2005; Lee et al., 2009). As reviewed
by Kimura et al. (2012), reciprocal interaction exists between neu-
rons and astrocytes: surrounding astrocytes are activated by neuronalFig. 6. AOA induces increase whereas Na2S evokes decrease in the AVPO PGE2 produc-
tion during fever. Effect of injection of LPS (100 μg/kg, ip) or saline (1 ml/kg, ip) com-
bined with icv microinjection of AOA (100 pmol in 2 μl), Na2S (260 nmol in 2 μl) or
vehicle (saline, 2 μl) on AVPO PGE2 levels. Values are means±SE. Number of animals
in each group is shown in parenthesis. ⁎Pb0.05 vs. Na2S+LPS, @Pb0.05 vs. saline+
LPS, #Pb0.05 vs. groups treated ip with saline, by one-way ANOVA followed by Tukey
post hoc test.
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H2S acts as a regulator of synaptic activity by enhancing the activity of
both neurons and astrocytes, and induces Ca2+ inﬂux in astrocytes
that propagates to the surrounding astrocytes (Enokido et al., 2005;
Nagai et al., 2004). Expectedly, reciprocal interactions also take
place between astrocytes and neurons in the AVPO, accounting for
the generation and control of fever (Blatteis, 2006; Feleder et al.,
2004). In this context, AVPO astrocytes stand for a common site of
production of both H2S from CBS and PGE2 from COX-2/mPGES-1.
Therefore, these cells are most likely to be the brain cells mainly
affected by the treatment with AOA, and to inﬂuence the warm-
sensitive neurons activity through PGE2 release (for a review see
Blatteis, 2006).
Considering H2S as an antipyretic molecule implies that this gas
does not affect Tb under normal conditions (euthermia) but is effec-
tive in attenuating the regulated increase in Tb (fever). Indeed, our
ﬁndings showed that central pharmacological inhibition of H2S pro-
duction with AOA (100 pmol) did not affect Tb of euthermic rats
whereas potentiated the febrile response in rats challenged with a
polyphasic fever-inducing dose of LPS (100 μg/kg, ip). In agreement
with the role of H2S in blunting fever, increased bioavailability of
this gas in the cerebroventricular system did blunt LPS fever, whereas
had no signiﬁcant effect on Tb.
To our knowledge, the present study is the ﬁrst to explore in vivo
and ex vivo the role of the CBS–H2S system in the most manifest and
familiar sign of the acute-phase reaction of systemic inﬂammation.
Interestingly, here we demonstrated not only that H2S acts in vivo
as an antipyretic molecule in the brain but also that LPS fever is ac-
companied by reduced levels of H2S in the hypothalamic region es-
sentially involved in the generation and control of fever, the AVPO.
The latter ﬁnding is in agreement with the in vitro study by Lee
et al. (2009) who showed that H2S production is suppressed by in-
ﬂammatory stimulation of astrocytes. The systemic inﬂammation-
associated suppression of AVPO H2S production (Fig. 3) is likely to re-
duce the suppressive effect of the gas on the AVPO PGE2 production,
thereby permitting the LPS-induced increase in the levels of PGE2 in
this fever-generating hypothalamic region (Fig. 6).
As reported by Boulant (1998) and reviewed by Steiner and
Branco (2003), both cAMP and cGMP have a profound impact on
the activity of warm-sensitive neurons of the preoptic hypothalamus,
triggering febrile response when their levels are reduced in the AVPO
following LPS exposure (Steiner et al., 2002a, 2002b). Consistent with
this fact, our ﬁndings showed that the levels of cAMP and cGMP were
reduced in the AVPO of LPS-treated rats. However, as to the putative
effect of H2S on the NOS–NO–sGC–cGMP system, our ﬁndings re-
vealed that, in spite of the fact that interactions have been reported
to exist between NO and H2S (Oh et al., 2006; Whiteman and
Moore, 2009; for a review see Kajimura et al., 2010), in the AVPO in-
teractions between these gaseous modulators do not seem to occur,
as in this hypothalamic region the treatment with AOA or Na2S did
not affect the levels of NOx and cGMP either during euthermia or dur-
ing fever.
The scenario seems different from that of cGMPwhenwe look at the
effects of H2S on the AVPO levels of cAMP and PGE2. Increased bioavail-
ability of H2S, besides attenuating fever, remarkably reduced the AVPO
PGE2 levels following the immunoinﬂammatory challenge. These ef-
fects clearly demonstrate the antipyretic capacity of H2S, conﬁrmed by
the attenuated fever (Figs. 2A and B),which adds to the existent data re-
garding the central antiinﬂammatory action of the gas in vitro (Lee
et al., 2009). Moreover, concomitant with the LPS exposure, the sup-
pression of endogenous H2S synthesis with AOA further enhanced the
PGE2 production in the AVPO and exacerbated the febrile response, pro-
viding again solid evidence of the antipyretic role of endogenous H2S.
This inhibitory effect of the gas on PGE2 synthesis has been postulated
to occur through inhibition of NFkappaB activation (Lee et al., 2009).
This possibility may be greatly strengthened by the fact that (i) LPSstrongly induces COX-2 and mPGES-1 through the MyD88-dependent
NFκB pathway in cultured astrocytes (Font-Nieves et al., 2012), and
(ii) the LPS-induced activation of NFkappaB has been shown to be
suppressed by H2S, leading to an inhibition of COX-2 expression (Li
et al., 2009; Oh et al., 2006).
As discussed here, induction of systemic inﬂammation with LPS
reduced the AVPO levels of H2S, and the combined treatment with
LPS and AOA revealed that H2S suppresses PGE2 synthesis in the
AVPO during fever, but not during euthermia. Additionally, our data
showed that the gas stimulates cAMP production, but only following
LPS exposure, at least in the AVPO. This H2S-mediated increased
synthesis of cAMP has been also shown in our previous report
(Kwiatkoski et al., 2012) and by others (Kimura, 2000; Njie-Mbye et
al., 2012; Shao et al., 2011). It has been proposed that such stimulato-
ry effect of the gas on the activity of adenylate cyclase is mediated by
KATP channels (Njie-Mbye et al., 2012), and interestingly, in a positive
feedback regulatory loop, the adenylate cyclase by-product, cAMP,
has been reported to increase the expression of CBS in astrocytes
(Kimura et al., 2012). Moreover, in addition to the above mentioned
inhibition mediated by H2S, it is also possible that cAMP itself may in-
hibit COX-2 expression (Tazawa et al., 1994; Wu et al., 2008), which
would characterize the existence of reciprocal interactions between
the COX-2/mPGES-1/PGE2 and adenylate cyclase/cAMP systems, as
PGE2 is known to inhibit adenylate cyclase activity (see below). This
cAMP-mediated inhibition of COX-2 would potentially be a mecha-
nism acting concomitantly with that of H2S-mediated NFkappaB inhi-
bition to reduce COX-2 activity.
Typically, in preoptic neurons PGE2 activates EP3 receptors to ulti-
mately produce fever (for a review see Morrison and Nakamura,
2011). Once activated, EP3 receptors inhibits adenylate cyclase activi-
ty through protein Gi/o, reducing the intracellular levels of cAMP
(Bilak et al., 2004; Steiner and Branco, 2002; Toh et al., 1995). Reduced
levels of cAMP inhibit the activity of warm-sensitive neurons of the
preoptic hypothalamus (Boulant, 1998; for a review see Steiner and
Branco, 2003), thereby releasing the tonic inhibitory (GABAergic) in-
puts onto rostral medullary raphe, generating fever (for a review see
Morrison and Nakamura, 2011).
Thus, alternatively or concomitantly to a greater inhibition of PGE2
production, increased levels of AVPO H2S can stimulate cAMP produc-
tion in the AVPO, thereby ultimately serving to prevent an exaggerat-
ed fever from occurring during systemic infectious challenges.Conclusions
Our data are consistent with the notion that the gaseous messen-
ger H2S is a powerful endogenous antipyretic molecule that may act
through suppression of PGE2 synthesis and/or stimulation of cAMP
production in the preoptic hypothalamus (Fig. 7).Conﬂict of interest
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Fig. 7. Possible neurochemical mechanism involved in LPS-induced fever. LPS induces
increase in PGE2 and decrease in H2S AVPO levels. Increased PGE2 is known to evoke
a decrease in cAMP, ultimately resulting in fever (see text for details). The LPS-
induced reduction of H2S favors the increase in PGE2 and diminishes the stimulatory
effect of the gas on the synthesis of cAMP. These modulatory effects of H2S on both
PGE2 and cAMP possibly represent the ways by which an increase in the AVPO levels
of this gaseous neuromodulator can attenuate fever, thus revealing its potent antipy-
retic role in the preoptic hypothalamus. Solid arrows represent the novelties of the
present study. LPS, lipopolysaccharide; PGE2, prostaglandin E2; cAMP, cyclic AMP; Tb,
deep body temperature; H2S, hydrogen sulﬁde; AVPO, anteroventral preoptic region
of the hypothalamus.
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